| http://www.w3.org/ns/prov#value | - MENLO PARK, Calif., May 20, 2014 -- Avalanche Biotechnologies, Inc., a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the appointment of Linda C. Bain as Chief Financial Officer.
|
